Alnylam Pharmaceuticals
ALNY
#448
Rank
NZ$90.37 B
Marketcap
NZ$684.07
Share price
-3.68%
Change (1 day)
55.96%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company